Cargando…
Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine
Autores principales: | Launay, Odile, Cachanado, Marine, Luong Nguyen, Liem B., Ninove, Laetitia, Lachâtre, Marie, Ben Ghezala, Inès, Bardou, Marc, Schmidt-Mutter, Catherine, Lacombe, Karine, Laine, Fabrice, Allain, Jean-Sébastien, Botelho-Nevers, Elisabeth, Tavolacci, Marie-Pierre, Chidiac, Christian, Pavese, Patricia, Dussol, Bertrand, Priet, Stéphane, Deplanque, Dominique, Touati, Amel, Curci, Laureen, Konate, Eleine, Ben Hamouda, Nadine, Besbes, Anissa, Nubret, Eunice, Capelle, Florence, Berard, Laurence, Rousseau, Alexandra, Tartour, Eric, Simon, Tabassome, de Lamballerie, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Massachusetts Medical Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258749/ https://www.ncbi.nlm.nih.gov/pubmed/35767474 http://dx.doi.org/10.1056/NEJMc2206711 |
Ejemplares similares
-
Persistance des anticorps neutralisants induits par le vaccin à protéine recombinante souche B1.531 contre les variants Omicron du SARS-COV-2
por: Launay, O., et al.
Publicado: (2023) -
Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial
por: Janssen, Cécile, et al.
Publicado: (2022) -
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years
por: Durier, Christine, et al.
Publicado: (2022) -
Persistance à six mois des réponses immunitaires induites par une vaccination COVID-19 hétérologue ChAdOx1-nCoV19/BNT162b2 et homologue BNT162b2 – cohorte ANRS0001S COV-POPART
por: Lachâtre, M., et al.
Publicado: (2023) -
Small Molecule Drugs in Inflammatory Bowel Diseases
por: Ben Ghezala, Inès, et al.
Publicado: (2021)